Kircher Tilo, Thienel Renate, Wagner Michael, Reske Martina, Habel Ute, Kellermann Thilo, Frommann Ingo, Schwab Sibylle, Wölwer Wolfgang, von Wilmsdorf Martina, Braus Dieter F, Schmitt Andrea, Rapp Alexander, Stöcker Tony, Shah N Jon, Henn Fritz A, Sauer Heinrich, Gaebel Wolfgang, Maier Wolfgang, Schneider Frank
Dept. of Psychiatry and Psychotherapy RWTH , University of Aachen, Pauwelsstr. 30, 52074, Aachen, Germany.
Eur Arch Psychiatry Clin Neurosci. 2009 Mar;259(2):72-9. doi: 10.1007/s00406-008-0837-4. Epub 2008 Sep 19.
The Neuregulin (NRG1) gene has been associated with schizophrenia, but its functional implications are largely unknown. Our aim was to assess differential brain activation between patients carrying an at-risk allele on the Neuregulin 1 gene and patients without this genetic risk. Neural signal changes between 14 first episode schizophrenia patients with the at risk allele (SNP8NRG221533) from the Icelandic core haplotype and 14 without were measured with fMRI during a working memory task. Patients without the at risk allele showed greater activations (P < 0.05; corrected) in the left hippocampus, precuneus and cerebellum, as well as the right anterior cingulate. Brain regions previously associated with the pathology of Schizophrenia are differentially affected in those with a genetic at risk status in the NRG1 gene. Heterogeneity of structural and functional measures within patients characterized by clinical phenotypes may be in part due to this genetic variation.
神经调节蛋白(NRG1)基因已被证实与精神分裂症有关,但其功能影响在很大程度上仍不清楚。我们的目的是评估携带神经调节蛋白1基因风险等位基因的患者与无此遗传风险的患者之间大脑激活的差异。在一项工作记忆任务中,通过功能磁共振成像(fMRI)测量了14名来自冰岛核心单倍型且携带风险等位基因(SNP8NRG221533)的首发精神分裂症患者和14名无此等位基因患者的神经信号变化。无风险等位基因的患者在左侧海马体、楔前叶、小脑以及右侧前扣带回表现出更强的激活(P < 0.05;校正后)。先前与精神分裂症病理相关的脑区在NRG1基因存在遗传风险状态的患者中受到不同程度的影响。以临床表型为特征的患者体内结构和功能指标的异质性可能部分归因于这种基因变异。